Related Experiment Video
Updated: Sep 28, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Interventional Diagnostic Procedure: a Practical Guide for the Assessment of Coronary Vascular Function
Daniel T Y Ang1, Novalia P Sidik1, Andrew J Morrow1
1Department of Cardiology, Golden Jubilee National Hospital; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow.
Insights
Many patients with angina have no obstructive coronary artery disease. Interventional diagnostic procedures (IDP) during angiography help identify abnormal coronary function, guiding personalized treatment for conditions like vasospastic angina.
Area of Science:
- Cardiology
- Interventional Cardiology
- Diagnostic Procedures
Background:
- Approximately 40% of patients with angina lack obstructive coronary artery disease (ANOCA).
- Abnormal coronary function underlies various endotypes, including coronary endothelial dysfunction, microvascular angina, vasospastic angina, and MINOCA.
- Established guidelines now exist for diagnosing and treating these conditions.
Purpose of the Study:
- To provide practical guidance on the preparation and administration of interventional diagnostic procedures (IDP) in clinical practice.
- To detail key preparation and safety considerations for successful procedural outcomes.
- To highlight how IDP supports stratified medicine and personalized patient care.
Main Methods:
- Coronary function tests are performed as adjunctive interventional diagnostic procedures (IDP) during coronary angiography.
- IDP comprises a diagnostic guidewire test (5 minutes) measuring flow limitation parameters (FFR, CFR, IMR) and a pharmacological coronary reactivity test (10-15 minutes).
- Pharmacological testing involves intra-coronary infusion of acetylcholine and glyceryl trinitrate (GTN) to assess vasodilator potential and vasospasm.
Main Results:
- The diagnostic guidewire test measures key parameters of coronary flow limitation and vasodilator function.
- The pharmacological test differentiates normal vasodilation from abnormal vasospasm, aiding diagnosis of vasospastic angina.
- IDP enables differentiation of patients according to specific endotypes based on distinct disease mechanisms.
Conclusions:
- Interventional diagnostic procedures (IDP) are crucial for identifying abnormal coronary function in patients with angina and no obstructive coronary artery disease.
- IDP facilitates the diagnosis of specific endotypes, enabling tailored therapeutic strategies.
- The application of IDP promotes a personalized approach to cardiovascular health, aligning with stratified medicine principles.
Abstract:
Approximately 40% of patients undergoing invasive coronary angiography for investigation of angina are found to have no obstructive coronary artery disease (ANOCA). Abnormal coronary function underlies coronary vasomotion syndromes including coronary endothelial dysfunction, microvascular angina, vasospastic angina, post-PCI angina and myocardial infarction with no obstructive coronary arteries (MINOCA). Each of these endotypes are distinct subgroups, characterized by specific disease mechanisms. Diagnostic criteria and linked therapy for these conditions are now established by expert consensus and clinical guidelines. Coronary function tests are performed as an adjunctive interventional diagnostic procedure (IDP) in appropriately selected patients during coronary angiography. This aids differentiation of patients according to endotype. The IDP includes two distinct components: a diagnostic guidewire test and a pharmacological coronary reactivity test. The tests last approximately 5 minutes for the former and 10-15 minutes for the latter. Patient safety and staff education are key. The diagnostic guidewire test measures parameters of coronary flow limitation (fractional flow reserve [FFR], coronary flow reserve [CFR], microvascular resistance [index of microvascular resistance (IMR)], basal resistance index, and vasodilator function [CFR, resistive reserve ratio (RRR)]). The pharmacological coronary reactivity test measures the vasodilator potential and propensity to vasospasm of both the main coronary arteries and the micro-vessels. It involves intra-coronary infusion of acetylcholine and glyceryl trinitrate (GTN). Acetylcholine is not licensed for parenteral use and is therefore prescribed on a named-patient basis. Vasodilatation is the normal, expected response to infusion of physiological concentrations of acetylcholine. Vascular spasm represents an abnormal response, which supports the diagnosis of vasospastic angina. The purpose of this practical guide is to provide information on the preparation and administration of the IDP in clinical practice. It discusses some key preparation and safety considerations, as well as tips for procedural success. The IDP supports stratified medicine for a personalized approach to health and wellbeing.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization III: Left Heart Catheterization
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...

